Patents by Inventor Luis Filipe Ferreira Neves

Luis Filipe Ferreira Neves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504745
    Abstract: Compositions for detecting and/or destroying cancer tumors and/or cancer cells via photodynamic therapy are disclosed, as well as methods of use thereof. The compositions comprise a linking protein or peptide attached to or otherwise physically associated with a carbon nanotube to form a targeted protein-carbon nanotube complex.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: November 29, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Roger G. Harrison, Jr., Daniel E. Resasco, Luis Filipe Ferreira Neves
  • Publication number: 20140155333
    Abstract: Compositions for detecting and/or destroying cancer tumors and/or cancer cells via photodynamic therapy are disclosed, as well as methods of use thereof. The compositions comprise a linking protein or peptide attached to or otherwise physically associated with a carbon nanotube to form a targeted protein-carbon nanotube complex.
    Type: Application
    Filed: December 9, 2013
    Publication date: June 5, 2014
    Applicant: The Board of Regents of the University of Oklahoma
    Inventors: Roger G. Harrison, JR., Daniel E. Resasco, Luis Filipe Ferreira Neves
  • Patent number: 8518870
    Abstract: The present invention is a method for detecting and destroying cancer tumors. The method is based on the concept of associating a linking protein or linking peptide such as, but not limited to, annexin V or other annexins to carbon nanotubes such as single-walled carbon nanotubes (SWNTs) to form a protein-CNT complex. Said linking protein or peptide can selectively bind to cancerous cells, especially tumor vasculature endothelial cells, rather than to healthy ones by binding to cancer-specific external receptors such as anionic phospholipids including phosphatidylserine expressed on the outer surfaces of cancer cells only. Irradiation of bound CNTs with one or more specific electromagnetic wavelengths is then used to detect and destroy those cells to which the CNTs are bound via the linking protein or peptide thereby destroying the tumor or cancer cells and preferably an immunostimulant is provided to the patient to enhance the immune response against antigens released from the tumor or cancer cells.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: August 27, 2013
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Roger G. Harrison, Jr., Daniel E. Resasco, Luis Filipe Ferreira Neves
  • Publication number: 20130183354
    Abstract: A method for detecting and/or destroying cancer tumors is based on the concept of associating a linking protein or linking peptide to carbon nanotubes to form a protein-carbon nanotube complex.
    Type: Application
    Filed: March 13, 2013
    Publication date: July 18, 2013
    Inventors: Roger G. Harrison, JR., Daniel E. Resasco, Luis Filipe Ferreira Neves